Evidence map›Paper›PMID 32708202›Full record

ReviewCells2020

Hyaluronic Acid: Redefining Its Role.

G Abatangelo, V Vindigni, G Avruscio, L Pandis, P Brun

2 registry-linked trialsOpen access · goldAbstract readReview
In one paragraph

Review in Cells, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 222 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
222citing papers in PubMed, 2 pooled it
23.3field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06774742 nacompletednot on this mapstarted 2025, after this paper: background citation

Evaluation of the Effects of a Dietary Supplement Containing a Full Range of Hyaluronic Acids in Healthy Female Subjects With Dry Facial Skin and Lips

TypeinterventionalSponsorTS Biotech - Shandong Tiansheng Biotechnology Co., LtdRan2025 to 2025Enrolled130ConditionsSkin Quality, Lips Quality, Persistence of the EffectArmsHAFS Supplementation, Placebo
NCT07376148 phase4recruitingnot on this mapstarted 2025, after this paper: background citation

Fractional CO2 Laser-assisted Delivery of Hyaluronic Acid, Ascorbic Acid and Sodium DNA For Enhancing Facial Skin Quality in Individuals Over the Age of 30

TypeinterventionalSponsorInstituto de Oftalmología Fundación Conde de ValencianaRan2025 to 2026Enrolled30ConditionsSkin Quality Improvement, Photo-aged Skin, Drug Delivery SystemsArmstopical hyaluronic acid, ascorbic acid, and sodium DNA following ablative fractional laser treatment
3 · Its place in the literature

Who cites it

222 citing papers in PubMed, 2 syntheses or guidelines pooled it, 486 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Trial
  5. Trial
  6. Trial
  7. Review
  8. Article
  9. Article
  10. Review
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Review
  19. Review
  20. Review

162 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

G AbatangeloFaculty of Medicine, University of Padova, 35121 Padova, Italy.
V VindigniClinic of Plastic and Reconstructive Surgery, University of Padova, 35128 Padova, Italy.
G AvruscioDepartment of Cardiac, Thoracic and Vascular Sciences, Angiology Unit, University of Padova, 35128 Padova, Italy.
L PandisClinic of Plastic and Reconstructive Surgery, University of Padova, 35128 Padova, Italy.
P BrunDepartment of Molecular Medicine, Histology unit, University of Padova, 35121 Padova, Italy.ORCID 0000-0002-4204-3549
University of Padua · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The discovery of several unexpected complex biological roles of hyaluronic acid (HA) has promoted new research impetus for biologists and, the clinical interest in several fields of medicine, such as ophthalmology, articular pathologies, cutaneous repair, skin remodeling, vascular prosthesis, adipose tissue engineering, nerve reconstruction and cancer therapy. In addition, the great potential of HA in medicine has stimulated the interest of pharmaceutical companies which, by means of new technologies can produce HA and several new derivatives in order to increase both the residence time in a variety of human tissues and the anti-inflammatory properties. Minor chemical modifications of the molecule, such as the esterification with benzyl alcohol (Hyaff-11

Indexed as

Adipose TissueAnimalsHumansHyaluronic AcidNeoplasmsReceptors, Cell SurfaceSkinTissue EngineeringHyaluronic AcidReceptors, Cell Surfacehyaluronic acid (HA), HA receptorsosteoarthritistissue-engineering

Identifiers

PMID32708202
PMCPMC7409253
OpenAlexW3043828730

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.